Evidence map›Paper›PMID 28404678›Full record

ArticleJournal of clinical microbiology2017

Antifungal Susceptibility Testing of Aspergillus spp. by Using a Composite Correlation Index (CCI)-Based Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method Appears To Not Offer Benefit over Traditional Broth Microdilution Testing.

Melissa R Gitman, Lisa McTaggart, Joanna Spinato, Rahgavi Poopalarajah, Erin Lister, Shahid Husain, Julianne V Kus

Abstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Optimizing MALDI-TOF MS for routine dermatophyte identification, including Trichophyton indotineae.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Studies in mycology · 2021
    Review
  5. Review
  6. Review
  7. Review
  8. Can We Improve Antifungal Susceptibility Testing?Frontiers in cellular and infection microbiology · 2021
    Review
  9. Antifungal Susceptibility Testing: Current Approaches.Clinical microbiology reviews · 2020
    Review
  10. Article
  11. (New) Methods for Detection ofCurrent fungal infection reports · 2019
    Article
  12. Susceptibility Testing of Fungi to Antifungal Drugs.Journal of fungi (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Melissa R GitmanMulti-Organ Transplant Unit, University Health Network, Toronto, ON, Canada.
Lisa McTaggartPublic Health Ontario, Toronto, ON, Canada.
Joanna SpinatoPublic Health Ontario, Toronto, ON, Canada.
Rahgavi PoopalarajahPublic Health Ontario, Toronto, ON, Canada.
Erin ListerPublic Health Ontario, Toronto, ON, Canada.
Shahid HusainMulti-Organ Transplant Unit, University Health Network, Toronto, ON, Canada.
Julianne V KusPublic Health Ontario, Toronto, ON, Canada julianne.kus@oahpp.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsAspergillusHumansMicrobial Sensitivity TestsProof of Concept StudySpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationVoriconazoleAntifungal AgentsVoriconazoleantifungal susceptibility testingAspergilluscomposite correlation indexMALDI-TOF MSvoriconazolevoriconazole resistance

Identifiers

PMID28404678
PMCPMC5483904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.